Expert guide on renal dosing adjustments for Metformin and SGLT2 inhibitors in diabetes. Covers eGFR thresholds, KDIGO guidelines, and navigating FDA label conflicts.
Tag: SGLT2 inhibitors
Euglycemic DKA on SGLT2 inhibitors is a dangerous, under-recognized condition where diabetic ketoacidosis occurs with normal blood sugar. Learn the symptoms, how to diagnose it, and what emergency care looks like - because normal glucose doesn’t mean safe.